Analysts: Vitamin Shoppe Lacks Catalysts and 3 More Research Notes to Check Out

Vitamin Shoppe (NYSE:VSI): Credit Suisse has downgraded Vitamin Shoppe to Neutral from Outperform due to top-line deceleration and a lack of catalysts for next year. The firm has lowered its price target, as well, to $46 from $55.

vsi-08122013

EV Energy (NASDAQ:EVEP): Oppenheimer has downgraded EV Energy to Perform from Outperform after assuming coverage of the stock. The firm cited the disappointing size of the company’s first Utica transaction and its equity needs.

evep-08122013

Synergy Pharmaceuticals (NASDAQ:SGYP): Cantor has reduced its price target to $11 from $15 on Synergy as the firm has begun valuing the company as a potential takeover target. It believes that larger drug companies have become more aware of the attractiveness of the IBS market and keeps a Buy rating on Synergy.

sygp-08122013

Merge Healthcare (NASDAQ:MRGE): RW Baird believes that the selloff of Merge Healthcare following its second-quarter results is overdone, citing a sum-of-the-parts analysis. The firm noted that management raised expectations with upbeat selling commentary but client spending slowed. The shares remain Outperform rated but the price target was lowered to $4 from $7.

mrge-08122013

Don’t Miss: Is the FCC Finally Ready to Step Into the Time Warner-CBS Cage Fight?

More Articles About:    

More from The Cheat Sheet